{"id":21826,"date":"2022-07-20T11:02:22","date_gmt":"2022-07-20T09:02:22","guid":{"rendered":"https:\/\/www.ntf.uni-lj.si\/ntf\/?post_type=notification&#038;p=21826"},"modified":"2022-09-07T10:58:33","modified_gmt":"2022-09-07T08:58:33","slug":"izzivi-mednarodnih-podjetij-09-2022","status":"publish","type":"notification","link":"https:\/\/www.ntf.uni-lj.si\/ntf\/notification\/izzivi-mednarodnih-podjetij-09-2022\/","title":{"rendered":"Izzivi mednarodnih podjetij (09\/2022)"},"content":{"rendered":"<p class=\"x_MsoNormal\"><b>CHINOOK THERAPEUTICS <\/b><b><a href=\"https:\/\/downloads.in-part.com\/discover\/campaigns\/WYxk8mep86eMyJNj\/call\/WYxk8mep86eMyJNj.pdf\" target=\"_blank\" rel=\"noopener noreferrer\" data-auth=\"NotApplicable\" data-linkindex=\"15\">Therapeutics for Glomerular and Autoimmune-related Kidney Diseases<\/a><\/b><\/p>\n<ul type=\"disc\">\n<li class=\"x_MsoListParagraphCxSpFirst\"><span lang=\"EN-US\">\ud83d\udc8a<\/span><span lang=\"EN-US\">\u00a0 Chinook Therapeutics is a clinical-stage biotechnology company developing precision medicines for kidney diseases.\u00a0The company is seeking to develop therapeutics targeting molecular drivers of kidney disease progression. They are interested in leveraging its precision medicine approach by identifying targets, mechanisms, and pathways with supporting biological validation data or genetic data showing strong correlation with human kidney disease.<\/span><b><\/b><\/li>\n<li class=\"x_MsoListParagraphCxSpLast\"><span lang=\"EN-US\">\ud83d\udca1<\/span><span class=\"x_MsoHyperlink\"><span lang=\"EN-US\">\u00a0<\/span><\/span><b><span lang=\"EN-US\">Approaches of Interest:<\/span><\/b><span lang=\"EN-US\">\u00a0Primary<\/span><span lang=\"EN-US\">\u00a0glomerular diseases. Autoimmune-related renal diseases. Rare or ultra-rare kidney disease indications, nephrolithiasis, polycystic kidney disease, and renal transplant. Novel genetic targets are of interest, as well as drug-repurposing approaches. Novel approaches for targeted delivery to specific cell types or compartments of the kidney.<\/span><\/li>\n<\/ul>\n<p class=\"x_MsoNormal\"><b>\u23f1\ufe0f Challenge deadline: 9th August\u00a02022<\/b><\/p>\n<p class=\"x_MsoNormal\"><b>BECKLEY PSYTECH <\/b><b><a href=\"https:\/\/downloads.in-part.com\/discover\/campaigns\/3VXyMYer86bOBQn6\/call\/3VXyMYer86bOBQn6.pdf\" target=\"_blank\" rel=\"noopener noreferrer\" data-auth=\"NotApplicable\" data-linkindex=\"16\">Seeking Serotonin Receptor Agonists to Elicit Psychedelic Effects, Neuroplasticity and Neurogenesis<\/a><\/b><\/p>\n<ul type=\"disc\">\n<li class=\"x_MsoListParagraph\"><span lang=\"EN-US\">\ud83d\udc8a<\/span><span lang=\"EN-US\">\u00a0 Beckley Psytech is dedicated to helping patients suffering from neurological and psychiatric disorders by developing a pipeline of psychedelic compounds into licensed pharmaceutical medicines. They are looking for universities that are working on serotonin (5HT2A) receptor agonists to elicit psychedelic effects, neuroplasticity, and neurogenesis.<\/span><\/li>\n<\/ul>\n<ul type=\"disc\">\n<li class=\"x_MsoListParagraph\"><span lang=\"EN-US\">\ud83d\udca1<\/span><span class=\"x_MsoHyperlink\"><span lang=\"EN-US\">\u00a0<\/span><\/span><b><span lang=\"EN-US\">Approaches of Interest:<\/span><\/b><span lang=\"EN-US\">\u00a0Therapeutic approaches to treat disorders where there is a significant unmet need. Therapeutic compounds with a suitable onset of action and duration of effect. Compound scaffolds based on tryptamine, ergoline or phenethylamine.\u00a0<b>Compounds with selectivity for 5HT2A<\/b>\u00a0are of the highest interest. Basic research into the activation of pathways downstream of 5HT2A binding. Novel approaches for the targeted delivery to cell types of the brain.<\/span><\/li>\n<\/ul>\n<p class=\"x_MsoNormal\"><b>\u23f1\ufe0f Challenge deadline: 9th August\u00a02022<\/b><\/p>\n<p class=\"x_MsoNormal\"><b>SHV ENERGY <\/b><b><a href=\"https:\/\/www.innoget.com\/technology-calls\/2108\/seeking-pathways-to-produce-c3-c4-saturated-hydrocarbons-lpg-with-high-yields-from-sustainable-feedstocks-abundantly-available-in-india\" target=\"_blank\" rel=\"noopener noreferrer\" data-auth=\"NotApplicable\" data-linkindex=\"17\">Seeking Pathways To Produce C3\/C4 Saturated Hydrocarbons (LPG) With High Yields From Sustainable Feedstocks Abundantly Available In India<\/a><\/b><\/p>\n<ul type=\"disc\">\n<li class=\"x_MsoListParagraphCxSpFirst\"><span lang=\"EN-US\">\ud83d\udd0b<\/span><span lang=\"EN-US\">\u00a0\u00a0LPG (Liquefied Petroleum Gas) is a clean and efficient fuel that can be used in a variety of applications, including cooking, heating, and transportation. LPG usage in India has increased dramatically in recent years, currently with over 300 million domestic users and 28 million tonnes of LPG used last year. SHV Energy also has a strong presence in the Indian market through our business unit SUPERGAS, with over 550 employees.<\/span><b><\/b><\/li>\n<li class=\"x_MsoListParagraphCxSpLast\"><span lang=\"EN-US\">\ud83d\udca1<\/span><span lang=\"EN-US\">\u00a0SHV Energy is looking for pathways that can produce saturated C3\/C4 hydrocarbons (LPG &#8211; propane and\/or butane\/iso-butane) from sustainable feedstocks with yields that could ultimately be scaled to make production commercially viable. The saturated C3\/C4 hydrocarbon may be a co-product with other similarly valuable components.<\/span><b><\/b><\/li>\n<\/ul>\n<p class=\"x_MsoNormal\"><b>\u23f1\ufe0f Challenge deadline: 31st\u00a0July\u00a02022<\/b><\/p>\n<p class=\"x_MsoNormal\"><b>TAKEDA <\/b><b><a href=\"https:\/\/www.halo.science\/research\/medicine\/lysosomal-and-gag-binders-to-create-pet-ligands\" target=\"_blank\" rel=\"noopener noreferrer\" data-auth=\"NotApplicable\" data-linkindex=\"18\">Small molecule binders of lysosomal proteins and glycosaminoglycans for eventual use as PET ligands<\/a><\/b><b><\/b><\/p>\n<ul type=\"disc\">\n<li class=\"x_MsoListParagraphCxSpFirst\"><span lang=\"EN-US\">\ud83d\udc69<\/span><span lang=\"EN-US\">\u200d<\/span><span lang=\"EN-US\">\u2695\ufe0f\u00a0<\/span><span lang=\"EN-US\">Takeda is a world leader in developing therapies to treat Lysosomal storage diseases. The company is currently seeking small molecule binders of glycosaminoglycans and\/or lysosome associated proteins to further our therapeutic studies.\u00a0 We will use these small molecules to develop PET (positron emission tomography) ligands to assess the efficacy of various treatments for multiple LSDs, first in animal studies and then in humans. We would also welcome computational screening platforms that could identify such small molecules. These PET ligands will be instrumental for our studies to understand how our therapies are affecting the pathology of the disease in real time, particularly in children and in the brain.<\/span><b><\/b><\/li>\n<li class=\"x_MsoListParagraphCxSpLast\"><span lang=\"EN-US\">\ud83d\udca1<\/span><span lang=\"EN-US\">\u00a0Takeda is seeking small molecule binders (&lt; 1,000 Da) and\/or binding motifs that can bind: Glycosaminoglycans, particularly heparan sulfate, Sphingolipids and Lysosomal proteins. Solutions of interest include: Small molecules with micromolar binding affinity to their targets. A computational screening platform for assessing and identifying polysaccharide-small molecule interactions.<\/span><b><\/b><\/li>\n<\/ul>\n<p class=\"x_MsoNormal\"><b>\u23f1\ufe0f Challenge deadline: 31st\u00a0July\u00a02022<\/b><\/p>\n<p class=\"x_MsoNormal\"><b>BAYER <\/b><b><a href=\"https:\/\/www.halo.science\/research\/agriculture\/grants4ag-enabling-technologies-for-plant-transformation\" target=\"_blank\" rel=\"noopener noreferrer\" data-auth=\"NotApplicable\" data-linkindex=\"19\">Grants4Ag: Enabling technologies for plant transformation<\/a><\/b><\/p>\n<ul type=\"disc\">\n<li class=\"x_MsoListParagraphCxSpFirst\"><span lang=\"EN-US\">\ud83c\udf31<\/span><span lang=\"EN-US\">\u00a0Worldwide demand for food, feed, and fuel is on the rise and will continue to increase significantly over the next several decades. The population is expected to reach almost ten billion people by 2030 and securing sufficient supply of quality food in an efficient and responsible way is critical. Bayer Crop Science is committed to ensure access to healthy, diverse, and safe food for a growing global population. Plant transformation is a key step in introducing novel traits that can improve our ability to provide sustainable food sources, particularly in row crops. Introducing new traits and gene-editing technology adds complexity to the transformation system and requires extensive research and innovation. We are looking to collaborate and support innovative scientists that can help us feed a growing planet.<\/span><b><\/b><\/li>\n<li class=\"x_MsoListParagraphCxSpLast\"><span lang=\"EN-US\">\ud83d\udca1<\/span><span lang=\"EN-US\">\u00a0The intent of this project is to enable research towards developing new plant transformation technologies for row crops, particularly monocots.\u00a0<b>Solutions of interest include:\u00a0<\/b>Novel ways to enhance starting material for plant transformation. Novel delivery systems into plant cells. Selection systems. Innovative ways to enhance regeneration into plants with heritable traits (e.g. morphogenic regulators). New methods to enhance crop transformation.<\/span><b><\/b><\/li>\n<\/ul>\n<p class=\"x_MsoNormal\"><b>\u23f1\ufe0f Challenge deadline: 31st\u00a0July\u00a02022<\/b><\/p>\n<p class=\"x_MsoNormal\"><b>PEPSICO <\/b><b><a href=\"https:\/\/www.halo.science\/research\/materials\/ghg-reduction-for-packaging\" target=\"_blank\" rel=\"noopener noreferrer\" data-auth=\"NotApplicable\" data-linkindex=\"20\">Materials and technologies for greenhouse gas reduction in packaging<\/a><\/b><\/p>\n<ul type=\"disc\">\n<li class=\"x_MsoListParagraphCxSpFirst\"><span lang=\"EN-US\">\ud83d\udce6<\/span><span lang=\"EN-US\">\u00a0PepsiCo has set out to achieve 100% RCBR (recyclable, compostable, biodegradable or reusable) compliance in packaging by 2025 and a 40% reduction in greenhouse gas (GHG) emissions by 2030. Many of our packaging types are already considered recyclable (e.g., PET bottles, aluminum cans, glass packaging). But to reach our goals we must reduce greenhouse gas emissions over the course of the packaging\u2019s entire lifecycle.<\/span><b><\/b><\/li>\n<li class=\"x_MsoListParagraphCxSpLast\"><span lang=\"EN-US\">\ud83d\udca1<\/span><span lang=\"EN-US\">\u00a0We are seeking technologies that will reduce GHG emissions during packaging production or over the entire lifecycle of PET bottles, aluminum cans, and glass packaging (and other types of packaging) without sacrificing packaging quality.\u00a0<b>Solutions of interest include:\u00a0<\/b>Highly functional materials, additives, or coatings that improve packaging properties (e.g., barrier, mechanical properties) and therefore can enable light weighting. Additives or coatings that reduce energy usage during packaging production resulting in lower GHG emissions. Packaging production processes with reduced energy usage.<\/span><b><\/b><\/li>\n<\/ul>\n<p class=\"x_MsoNormal\"><b>\u23f1\ufe0f Challenge deadline: 31st\u00a0July\u00a02022<\/b><\/p>\n<p class=\"x_MsoNormal\"><b>PEPSICO <\/b><b><a href=\"https:\/\/www.halo.science\/research\/food\/technologies-to-minimize-salt-perception-of-electrolytes\" target=\"_blank\" rel=\"noopener noreferrer\" data-auth=\"NotApplicable\" data-linkindex=\"21\">Technologies to minimize the salty taste of electrolytes<\/a><\/b><\/p>\n<ul type=\"disc\">\n<li class=\"x_MsoListParagraphCxSpFirst\"><span lang=\"EN-US\">\ud83e\uddc2<\/span><span lang=\"EN-US\">\u00a0PepsiCo is seeking new technologies to minimize the perception of a salty taste in beverages containing electrolytes.<\/span><b><\/b><\/li>\n<li class=\"x_MsoListParagraphCxSpLast\"><span lang=\"EN-US\">\ud83d\udca1<\/span><span lang=\"EN-US\">\u00a0PepsiCo is open to a range of collaboration types, but the technology should be available for scale-up within the next 3 year.\u00a0<b>Solutions of interest include:\u00a0<\/b>Taste advantaged salts (less salty than NaCl), other mineral ingredients, or blends that can mask\/balance saltiness. Encapsulation\/plating technologies to reduce the perception of saltiness. Ion exchange\/ion binding to remove salty tasting anions. Salt receptor blockers.<\/span><b><\/b><\/li>\n<\/ul>\n<p class=\"x_MsoNormal\"><b>\u23f1\ufe0f Challenge deadline: 31st\u00a0July\u00a02022<\/b><\/p>\n<p class=\"x_MsoNormal\"><b>HALO SCIENCE <\/b><b><a href=\"https:\/\/www.halo.science\/research\/hygiene\/filtering-technology-to-remove-chemicals-odors-vocs-and-pathogens\" target=\"_blank\" rel=\"noopener noreferrer\" data-auth=\"NotApplicable\" data-linkindex=\"22\">Technology to remove chemicals, odors, VOCs and pathogens in air<\/a><\/b><\/p>\n<ul type=\"disc\">\n<li class=\"x_MsoListParagraphCxSpFirst\"><span lang=\"EN-US\">\ud83d\ude16<\/span><span lang=\"EN-US\">\u00a0Normal HEPA filters are great for removing particles but don&#8217;t remove or destroy chemicals or odors that are in vapor phase. Today the best most common technology to use to remove these chemicals and odors in air involves using activated carbon, which often don&#8217;t last the life of the filter and\/or lose effectiveness in a few weeks. We are interested in novel technologies that can remove these odors, chemicals and volatile organic compounds (VOCs) from the air. It would also be advantageous if the technology eliminates or inactivates bacteria, virus, molds and other pathogens.<\/span><b><\/b><\/li>\n<li class=\"x_MsoListParagraphCxSpLast\"><span lang=\"EN-US\">\ud83d\udca1<\/span><span lang=\"EN-US\">\u00a0We are seeking technologies that remove, destroy, or eliminate chemicals and odors in air. A second priority would be also to eliminate, destroy or inactivate pathogens in the air.\u00a0<b>Solutions of interest include:\u00a0<\/b>Add-on component or device that moves air and contains filtration media, materials, or filter coating\/treatment. Module (e.g. plasma, UVC, catalyst) within the device.<\/span><b><\/b><\/li>\n<\/ul>\n<p class=\"x_MsoNormal\"><b>\u23f1\ufe0f Challenge deadline: 31st\u00a0July\u00a02022<\/b><\/p>\n<p class=\"x_MsoNormal\"><b>ALMIRALL <\/b><b><a href=\"https:\/\/downloads.in-part.com\/discover\/campaigns\/8DKgl9avlrdG1vzA\/call\/8DKgl9avlrdG1vzA.pdf\" target=\"_blank\" rel=\"noopener noreferrer\" data-auth=\"NotApplicable\" data-linkindex=\"23\">Seeking Innovative Therapies for the Treatment of Skin Disorders<\/a><\/b><\/p>\n<ul type=\"disc\">\n<li class=\"x_MsoListParagraphCxSpFirst\"><span lang=\"EN-US\">\ud83e\uddd1<\/span><span lang=\"EN-US\">\u00a0 Almirall is a global biopharmaceutical company focused on skin health based in Barcelona. They collaborate with scientists and healthcare professionals to address patient\u2019s needs and make a difference in their lives. They invest in differentiated and ground breaking medical dermatology products to bring their innovative solutions to patients in need.<\/span><\/li>\n<li class=\"x_MsoListParagraphCxSpLast\"><span lang=\"EN-US\">\ud83d\udca1<\/span><span lang=\"EN-US\">Almirall is seeking partnering opportunities on new assets in preclinical or clinical development stages that could be useful for the treatment of dermatological diseases. The proposed new assets should: Target immuno-inflammatory pathways with rationale for dermatological indications. Be suitable for non-melanoma skin cancer, or rare dermatological indications. Involve any therapeutic modality such as small molecules, biologics, mRNA therapeutics or gene therapy approaches<\/span><\/li>\n<\/ul>\n<p class=\"x_MsoNormal\"><b>\u23f1\ufe0f Challenge deadline: 16th August\u00a02022<\/b><\/p>\n<p class=\"x_MsoNormal\"><b><span lang=\"EN-US\">MARS PETCARE <\/span><\/b><b><\/b><b><span lang=\"EN-US\"><a href=\"https:\/\/downloads.in-part.com\/discover\/campaigns\/pPy7LDdwVwb1YKXA\/call\/pPy7LDdwVwb1YKXA.pdf\" target=\"_blank\" rel=\"noopener noreferrer\" data-auth=\"NotApplicable\" data-linkindex=\"24\">Seeking Fermentation Technology to Enhance Cat Palatability<\/a><\/span><\/b><\/p>\n<ul type=\"disc\">\n<li class=\"x_MsoListParagraphCxSpFirst\"><span lang=\"EN-US\">\ud83d\ude3a<\/span><span lang=\"EN-US\">\u00a0 Mars Petcare is a leading provider of high quality, science<\/span><span lang=\"EN-US\">\u2011<\/span><span lang=\"EN-US\">backed nutrition and therapeutic health products. Through comprehensive veterinary care, nutrition, breakthrough programs in diagnostics, wearable health monitoring, DNA testing and pet welfare, their 100,000 Petcare Associates help pets in more than 130 countries.<\/span><\/li>\n<\/ul>\n<ul type=\"disc\">\n<li class=\"x_MsoListParagraphCxSpLast\"><span lang=\"EN-US\">\ud83d\udca1\u00a0<\/span><span lang=\"EN-US\">Mars Petcare are looking for fermentation technologies to transform raw materials to boost product flavour and attractiveness for cats and dogs. There is particular interest in research studies that demonstrate success in transforming raw material into palatants, or taste and aroma enhancers (e.g., Umami, Kokumi or others).<\/span><b><\/b><\/li>\n<\/ul>\n<p class=\"x_MsoNormal\"><b>\u23f1\ufe0f Challenge deadline: 23rd August\u00a02022<\/b><\/p>\n<p class=\"x_MsoNormal\"><b>FAURECIA <\/b><b><span lang=\"EN-US\"><a href=\"https:\/\/downloads.in-part.com\/discover\/campaigns\/LkQWjnegZ9dwZ1p0\/call\/LkQWjnegZ9dwZ1p0.pdf\" target=\"_blank\" rel=\"noopener noreferrer\" data-auth=\"NotApplicable\" data-linkindex=\"25\">Seeking Sustainable Skin Composites as an Alternative for Leather and Synthetic Leather<\/a><\/span><\/b><\/p>\n<ul type=\"disc\">\n<li class=\"x_MsoListParagraphCxSpFirst\"><span lang=\"EN-US\">\ud83c\udffb<\/span><span lang=\"EN-US\">\u00a0Faurecia, a company of the Group FORVIA, is a tier<\/span><span lang=\"EN-US\">\u2011<\/span><span lang=\"EN-US\">one automotive supplier with a carbon neutrality target over the coming years. Faurecia Interiors Systems and Faurecia Seating are important users of skins, artificial leather, and textiles for premium visual and haptic aspect. Usually, leather and PVC\/PU (leatherette) are used as a covering material for the dashboard, door panel and seat. Each interior part has specific requirements in terms of skin properties (abrasion, mechanical, etc).<\/span><\/li>\n<\/ul>\n<p class=\"x_MsoListParagraphCxSpMiddle\"><span lang=\"EN-US\">It is well known that leather has an important carbon footprint and moreover, adds recycling challenges when reaching end<\/span><span lang=\"EN-US\">\u2011<\/span><span lang=\"EN-US\">of<\/span><span lang=\"EN-US\">\u2011<\/span><span lang=\"EN-US\">life.<\/span><\/p>\n<p class=\"x_MsoListParagraphCxSpLast\"><span lang=\"EN-US\">\ud83d\udca1 T<\/span><span lang=\"EN-US\">he Sustainable Materials Division at Faurecia aims at developing low carbon footprint alternative skins\/artificial leather\/textiles to decrease the emission factors of interior parts. The visual and haptic aspect will also be a challenge for the final user validation.<\/span><b><\/b><\/p>\n<p class=\"x_MsoNormal\"><b>\u23f1\ufe0f Challenge deadline: 23rd August\u00a02022<\/b><\/p>\n<p class=\"x_MsoNormal\"><b>ENEL <\/b><b><a href=\"https:\/\/openinnovability.enel.com\/challenges\/call\/2022\/5\/new-design-primary-substations\" target=\"_blank\" rel=\"noopener noreferrer\" data-auth=\"NotApplicable\" data-linkindex=\"26\">New design for sustainable Enel Primary Substation<\/a><\/b><\/p>\n<ul type=\"disc\">\n<li class=\"x_MsoListParagraphCxSpFirst\"><span lang=\"EN-US\">\ud83d\udd0b<\/span><span lang=\"EN-US\">\u00a0\u00a0Enel Global Infrastructure Networks is looking for a new design and architectural concept for the construction of a new and innovative sustainable building system dedicated to primary substations.<\/span><\/li>\n<li class=\"x_MsoListParagraphCxSpLast\"><span lang=\"EN-US\">\ud83d\udca1<\/span><span lang=\"EN-US\">\u00a0The new sustainable Enel Primary Substation must have innovative features in terms of design, materials and construction, incorporating principles of sustainability within a circular design approach; the substation must fully integrate in and garner the acceptance of the environmental and social contexts it is installed in. The new design must allow the observance of the technical and safety regulations currently complied with as well as maintaining the full functionality of the substation and equipment installed inside.<\/span><b><\/b><\/li>\n<\/ul>\n<p class=\"x_MsoNormal\"><b>\u23f1\ufe0f Challenge deadline: 31st\u00a0August\u00a02022<\/b><\/p>\n<p class=\"x_MsoNormal\"><b>ENEL <\/b><b><a href=\"https:\/\/openinnovability.enel.com\/challenges\/call\/2022\/5\/new-design-sustainable-secondary-substations\" target=\"_blank\" rel=\"noopener noreferrer\" data-auth=\"NotApplicable\" data-linkindex=\"27\">New design for sustainable Enel Secondary Substation<\/a><\/b><\/p>\n<ul type=\"disc\">\n<li class=\"x_MsoListParagraphCxSpFirst\"><span lang=\"EN-US\">\ud83d\udd0b<\/span><span lang=\"EN-US\">\u00a0\u00a0The primary goal of the challenge is the creation of an innovative sustainable architectonic modular system that allows a high degree of versatility, a necessary requirement to adapt the buildings and architectural elements to the different contexts of use present in the territory.<\/span><\/li>\n<li class=\"x_MsoListParagraphCxSpLast\"><span lang=\"EN-US\">\ud83d\udca1<\/span><span lang=\"EN-US\">\u00a0Enel Grids is looking for a new design concept for a prefabricated secondary substation, which must have innovative features in design, materials, and construction, incorporating the principles of sustainability and, in particular, a circular by design approach. The new design must ensure, both in the technical characteristics and in those of the product, the complete compliance with the technical and safety regulations currently in force for its use and installation, and must take into account the minimum dimensions necessary to house all the equipment normally found inside.<\/span><b><\/b><\/li>\n<\/ul>\n<p class=\"x_MsoNormal\"><b>\u23f1\ufe0f Challenge deadline: 31st\u00a0August\u00a02022<\/b><\/p>\n","protected":false},"excerpt":{"rendered":"CHINOOK THERAPEUTICS Therapeutics for Glomerular and Autoimmune-related Kidney Diseases \ud83d\udc8a\u00a0 Chinook Therapeutics is a clinical-stage biotechnology company developing precision medicines for kidney diseases.\u00a0The company is seeking to develop therapeutics targeting molecular drivers of kidney disease progression. They are interested in leveraging its precision medicine approach by identifying targets, mechanisms, and pathways with supporting biological validation &#8230; <a class=\"view-article\" href=\"https:\/\/www.ntf.uni-lj.si\/ntf\/notification\/izzivi-mednarodnih-podjetij-09-2022\/\">Read more<\/a>","protected":false},"author":206,"featured_media":0,"template":"","categories":[390],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v17.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ntf.uni-lj.si\/ntf\/notification\/izzivi-mednarodnih-podjetij-09-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Izzivi mednarodnih podjetij (09\/2022) - NTF\" \/>\n<meta property=\"og:description\" content=\"CHINOOK THERAPEUTICS Therapeutics for Glomerular and Autoimmune-related Kidney Diseases \ud83d\udc8a\u00a0 Chinook Therapeutics is a clinical-stage biotechnology company developing precision medicines for kidney diseases.\u00a0The company is seeking to develop therapeutics targeting molecular drivers of kidney disease progression. They are interested in leveraging its precision medicine approach by identifying targets, mechanisms, and pathways with supporting biological validation ... Read more\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ntf.uni-lj.si\/ntf\/notification\/izzivi-mednarodnih-podjetij-09-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"NTF\" \/>\n<meta property=\"article:modified_time\" content=\"2022-09-07T08:58:33+00:00\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"9 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ntf.uni-lj.si\/ntf\/#website\",\"url\":\"https:\/\/www.ntf.uni-lj.si\/ntf\/\",\"name\":\"NTF\",\"description\":\"Naravoslovnotehni\\u0161ka fakulteta\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ntf.uni-lj.si\/ntf\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ntf.uni-lj.si\/ntf\/notification\/izzivi-mednarodnih-podjetij-09-2022\/#webpage\",\"url\":\"https:\/\/www.ntf.uni-lj.si\/ntf\/notification\/izzivi-mednarodnih-podjetij-09-2022\/\",\"name\":\"Izzivi mednarodnih podjetij (09\/2022) - NTF\",\"isPartOf\":{\"@id\":\"https:\/\/www.ntf.uni-lj.si\/ntf\/#website\"},\"datePublished\":\"2022-07-20T09:02:22+00:00\",\"dateModified\":\"2022-09-07T08:58:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ntf.uni-lj.si\/ntf\/notification\/izzivi-mednarodnih-podjetij-09-2022\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ntf.uni-lj.si\/ntf\/notification\/izzivi-mednarodnih-podjetij-09-2022\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ntf.uni-lj.si\/ntf\/notification\/izzivi-mednarodnih-podjetij-09-2022\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Domov\",\"item\":\"https:\/\/www.ntf.uni-lj.si\/ntf\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Obvestila\",\"item\":\"https:\/\/www.ntf.uni-lj.si\/ntf\/notification\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Izzivi mednarodnih podjetij (09\/2022)\"}]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ntf.uni-lj.si\/ntf\/notification\/izzivi-mednarodnih-podjetij-09-2022\/","og_locale":"en_US","og_type":"article","og_title":"Izzivi mednarodnih podjetij (09\/2022) - NTF","og_description":"CHINOOK THERAPEUTICS Therapeutics for Glomerular and Autoimmune-related Kidney Diseases \ud83d\udc8a\u00a0 Chinook Therapeutics is a clinical-stage biotechnology company developing precision medicines for kidney diseases.\u00a0The company is seeking to develop therapeutics targeting molecular drivers of kidney disease progression. They are interested in leveraging its precision medicine approach by identifying targets, mechanisms, and pathways with supporting biological validation ... Read more","og_url":"https:\/\/www.ntf.uni-lj.si\/ntf\/notification\/izzivi-mednarodnih-podjetij-09-2022\/","og_site_name":"NTF","article_modified_time":"2022-09-07T08:58:33+00:00","twitter_misc":{"Est. reading time":"9 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebSite","@id":"https:\/\/www.ntf.uni-lj.si\/ntf\/#website","url":"https:\/\/www.ntf.uni-lj.si\/ntf\/","name":"NTF","description":"Naravoslovnotehni\u0161ka fakulteta","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ntf.uni-lj.si\/ntf\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.ntf.uni-lj.si\/ntf\/notification\/izzivi-mednarodnih-podjetij-09-2022\/#webpage","url":"https:\/\/www.ntf.uni-lj.si\/ntf\/notification\/izzivi-mednarodnih-podjetij-09-2022\/","name":"Izzivi mednarodnih podjetij (09\/2022) - NTF","isPartOf":{"@id":"https:\/\/www.ntf.uni-lj.si\/ntf\/#website"},"datePublished":"2022-07-20T09:02:22+00:00","dateModified":"2022-09-07T08:58:33+00:00","breadcrumb":{"@id":"https:\/\/www.ntf.uni-lj.si\/ntf\/notification\/izzivi-mednarodnih-podjetij-09-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ntf.uni-lj.si\/ntf\/notification\/izzivi-mednarodnih-podjetij-09-2022\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ntf.uni-lj.si\/ntf\/notification\/izzivi-mednarodnih-podjetij-09-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Domov","item":"https:\/\/www.ntf.uni-lj.si\/ntf\/"},{"@type":"ListItem","position":2,"name":"Obvestila","item":"https:\/\/www.ntf.uni-lj.si\/ntf\/notification\/"},{"@type":"ListItem","position":3,"name":"Izzivi mednarodnih podjetij (09\/2022)"}]}]}},"_links":{"self":[{"href":"https:\/\/www.ntf.uni-lj.si\/ntf\/wp-json\/wp\/v2\/notification\/21826"}],"collection":[{"href":"https:\/\/www.ntf.uni-lj.si\/ntf\/wp-json\/wp\/v2\/notification"}],"about":[{"href":"https:\/\/www.ntf.uni-lj.si\/ntf\/wp-json\/wp\/v2\/types\/notification"}],"author":[{"embeddable":true,"href":"https:\/\/www.ntf.uni-lj.si\/ntf\/wp-json\/wp\/v2\/users\/206"}],"version-history":[{"count":1,"href":"https:\/\/www.ntf.uni-lj.si\/ntf\/wp-json\/wp\/v2\/notification\/21826\/revisions"}],"predecessor-version":[{"id":21827,"href":"https:\/\/www.ntf.uni-lj.si\/ntf\/wp-json\/wp\/v2\/notification\/21826\/revisions\/21827"}],"wp:attachment":[{"href":"https:\/\/www.ntf.uni-lj.si\/ntf\/wp-json\/wp\/v2\/media?parent=21826"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ntf.uni-lj.si\/ntf\/wp-json\/wp\/v2\/categories?post=21826"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}